<SEC-DOCUMENT>0001062993-23-022548.txt : 20231214
<SEC-HEADER>0001062993-23-022548.hdr.sgml : 20231214
<ACCEPTANCE-DATETIME>20231214084824
ACCESSION NUMBER:		0001062993-23-022548
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20231213
FILED AS OF DATE:		20231214
DATE AS OF CHANGE:		20231214

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ImmunoPrecise Antibodies Ltd.
		CENTRAL INDEX KEY:			0001715925
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			A1
		FISCAL YEAR END:			0430

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39530
		FILM NUMBER:		231485711

	BUSINESS ADDRESS:	
		STREET 1:		880 - 580 HORNBY STREET
		CITY:			VANCOUVER
		STATE:			A1
		ZIP:			V6C3B6
		BUSINESS PHONE:		6048060626

	MAIL ADDRESS:	
		STREET 1:		880 - 580 HORNBY STREET
		CITY:			VANCOUVER
		STATE:			A1
		ZIP:			V6C3B6
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>form6k.htm
<DESCRIPTION>FORM 6-K
<TEXT>
<html>

<head>
    <title>ImmunoPrecise Antibodies Ltd.: Form 6-K - Filed by newsfilecorp.com</title>
</head>

<body style="font-size:10pt; font-family:'Times New Roman';">
    <hr width="100%" size="3" color="black" noshade="noshade"><a name="page_1"></a>
    <p style="margin-bottom: 0pt; text-align: center;"><font style="font-size: 18pt;"><b>UNITED STATES </b></font></p>
    <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><b><font style="font-size: 18pt;">SECURITIES AND EXCHANGE COMMISSION</font> </b></p>
    <p style="margin-top: 0pt; text-align: center;">Washington, D.C. 20549</p>
    <p style="text-align: center;"><font style="font-size: 18pt;"><b>Form 6-K</b></font></p>
    <p style="margin-bottom: 0pt; text-align: center;"><b>REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 </b></p>
    <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><b>OF THE SECURITIES EXCHANGE ACT OF 1934 </b></p>
    <p style="margin-top: 0pt; text-align: justify;">For the month of <u><b>December, 2023</b></u>.</p>
    <p style="text-align: justify;">Commission File Number: <u><b>001-39530</b></u></p>
    <p style="text-align: center;"><font style="font-size: 18pt;"><u><b> ImmunoPrecise Antibodies Ltd.</b> </u></font></p>
    <p style="margin-bottom: 0pt; text-align: center;"><u><b>3204 - 4464 Markham Street, Victoria, British Columbia V8Z 7X8</b></u></p>
    <p style="margin-top: 0pt; text-align: center;">(Address of principal executive office)</p>
    <hr style="border-top-style: none; border-bottom: 0.75pt solid #000000; margin-left: 108pt;">
    <p style="text-align: justify;">Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.</p>
    <table style="width: 29%; border-collapse: collapse; font-size: 10pt;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="margin-top: 0pt; margin-bottom: 0pt;">
                <p>Form 20-F&#160; &#9744;</p>
            </td>
            <td style="margin-top: 0pt; margin-bottom: 0pt;">
                <p>Form 40-F&#160; &#9746;</p>
            </td>
        </tr>
    </table>
    <br>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_2"></a>
    <p style="text-align: center;"><b>INCORPORATION BY REFERENCE</b></p>
    <p style="text-align: justify;">Exhibit 99.1 of this Form 6-K is incorporated by reference into the <a href="http://www.sec.gov/Archives/edgar/data/1715925/000106299323014797/formf3.htm">Registration Statement on Form F-3 (File No. 333-273197)</a> and <a href="http://www.sec.gov/Archives/edgar/data/1715925/000119312521180096/d11553ds8.htm">Registration Statement on Form S-8 (File No. 333-256730)</a> of the Registrant, ImmunoPrecise<b> </b>Antibodies Ltd.</p>
    <p style="text-align: center;"><b>EXHIBIT INDEX</b></p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 5%; vertical-align: bottom; border-bottom: 0.75pt solid #000000; padding-left: 4pt; padding-right: 4pt;">
                <p style="text-align: center; margin-top: 0pt;"><b>Exhibit</b></p>
            </td>
            <td style="width: 2%; vertical-align: bottom;">&#160;</td>
            <td style="margin-top: 0pt; width: 91.3295%; border-bottom: 0.75pt solid #000000;">
                <p><b>Description</b></p>
            </td>
        </tr>
        <tr>
            <td style="width: 5%; padding-left: 4pt; vertical-align: top; background-color: #eeeeee; padding-right: 4pt;">
                <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: right;"><a href="exhibit99-1.htm">99.1</a></p>
            </td>
            <td style="width: 2%; padding-left: 7.2pt; vertical-align: top; background-color: #eeeeee;">&#160;</td>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 91.3295%; background-color: #eeeeee;">
                <p><a href="exhibit99-1.htm">Material Change Report dated December 13, 2023</a></p>
            </td>
        </tr>
    </table>
    <br>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_3"></a>
    <p style="text-align: center;"><u><b>SIGNATURES </b></u></p>
    <p style="text-align: justify;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 50%;">
                <p>&#160;</p>
            </td>
            <td style="margin-top: 0pt; margin-bottom: 0pt;" colspan="2">
                <p><b>IMMUNOPRECISE ANTIBODIES LTD.</b></p>
            </td>
        </tr>
        <tr>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 50%;">
                <p>Date: December 14, 2023</p>
            </td>
            <td style="margin-top: 0pt; margin-bottom: 0pt;" colspan="2">
                <p>&#160;</p>
            </td>
        </tr>
        <tr>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 50%;">
                <p>&#160;</p>
            </td>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 5%;">
                <p>&#160;</p>
            </td>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 45%;">
                <p>&#160;</p>
            </td>
        </tr>
        <tr>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 50%;">
                <p>&#160;</p>
            </td>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 5%;">
                <p>By:</p>
            </td>
            <td style="margin-top: 0pt; width: 45%; border-bottom: 0.75pt solid #000000;">
                <p>/s/ Kristin Taylor</p>
            </td>
        </tr>
        <tr>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 50%;">
                <p>&#160;</p>
            </td>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 5%; padding-right: 5pt;">
                <p>Name:</p>
            </td>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 45%;">
                <p>Kristin Taylor</p>
            </td>
        </tr>
        <tr>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 50%;">
                <p>&#160;</p>
            </td>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 5%; padding-right: 5pt;">
                <p>Title:</p>
            </td>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 45%;">
                <p>Chief Financial Officer</p>
            </td>
        </tr>
    </table>
    <br>
    <hr width="100%" size="5" color="black" noshade="noshade">
</body>

</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>

<head>
    <title>ImmunoPrecise Antibodies Ltd.: Exhibit 99.1 - Filed by newsfilecorp.com</title>
</head>

<body style="font-size:10pt; font-family:'Times New Roman';">
    <hr width="100%" size="3" color="black" noshade="noshade"><a name="page_1"></a>
    <p style="text-align: center;"><b>FORM 51-102F3</b></p>
    <p style="text-align: center;"><b>MATERIAL CHANGE REPORT</b></p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 10%; vertical-align: top;">
                <p style="text-align: justify; margin-top: 0pt; margin-bottom: 0pt;"><b>Item 1</b></p>
            </td>
            <td style="width: 90%; vertical-align: top;">
                <p style="text-align: justify; margin-top: 0pt; margin-bottom: 0pt;"><b>Name and Address of Company</b></p>
            </td>
        </tr>
        <tr>
            <td style="width: 10%; vertical-align: top;">&#160;</td>
            <td style="width: 90%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
            <td style="width: 10%; vertical-align: top;">
                <p style="text-align: justify; margin-top: 0pt; margin-bottom: 0pt;">&#160;</p>
            </td>
            <td style="width: 90%; vertical-align: top;">
                <p style="margin-bottom: 0pt;">ImmunoPrecise Antibodies Ltd. (the <b>Company</b>)<br>3204 4464 Markham Street,</p>
                <p style="margin-top: 0pt; margin-bottom: 0pt;">Victoria, British Columbia, V8Z 7X8, Canada</p>
            </td>
        </tr>
        <tr>
            <td style="width: 10%; vertical-align: top;">&#160;</td>
            <td style="width: 90%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
            <td style="width: 10%; vertical-align: top;">
                <p style="text-align: justify; margin-top: 0pt; margin-bottom: 0pt;"><b>Item 2</b></p>
            </td>
            <td style="width: 90%; vertical-align: top;">
                <p style="text-align: justify; margin-top: 0pt; margin-bottom: 0pt;"><b>Date of Material Change</b></p>
            </td>
        </tr>
        <tr>
            <td style="width: 10%; vertical-align: top;">&#160;</td>
            <td style="width: 90%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
            <td style="width: 10%; vertical-align: top;">
                <p style="text-align: justify; margin-top: 0pt; margin-bottom: 0pt;">&#160;</p>
            </td>
            <td style="width: 90%; vertical-align: top;">
                <p style="text-align: justify; margin-top: 0pt; margin-bottom: 0pt;">December 8, 2023</p>
            </td>
        </tr>
        <tr>
            <td style="width: 10%; vertical-align: top;">&#160;</td>
            <td style="width: 90%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
            <td style="width: 10%; vertical-align: top;">
                <p style="text-align: justify; margin-top: 0pt; margin-bottom: 0pt;"><b>Item 3</b></p>
            </td>
            <td style="width: 90%; vertical-align: top;">
                <p style="text-align: justify; margin-top: 0pt; margin-bottom: 0pt;"><b>News Releases</b></p>
            </td>
        </tr>
        <tr>
            <td style="width: 10%; vertical-align: top;">&#160;</td>
            <td style="width: 90%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
            <td style="width: 10%; vertical-align: top;">
                <p style="text-align: justify; margin-top: 0pt; margin-bottom: 0pt;"><b>&#160;</b></p>
            </td>
            <td style="width: 90%; vertical-align: top;">
                <p style="text-align: justify; margin-top: 0pt; margin-bottom: 0pt;">A news release with respect to the material change was disseminated by the Company on December 8, 2023 through Business Wire and subsequently filed on SEDAR+.</p>
            </td>
        </tr>
        <tr>
            <td style="width: 10%; vertical-align: top;">&#160;</td>
            <td style="width: 90%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
            <td style="width: 10%; vertical-align: top;">
                <p style="text-align: justify; margin-top: 0pt; margin-bottom: 0pt;"><b>Item 4</b></p>
            </td>
            <td style="width: 90%; vertical-align: top;">
                <p style="text-align: justify; margin-top: 0pt; margin-bottom: 0pt;"><b>Summary of Material Change</b></p>
            </td>
        </tr>
        <tr>
            <td style="width: 10%; vertical-align: top;">&#160;</td>
            <td style="width: 90%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
            <td style="width: 10%; vertical-align: top;">
                <p style="text-align: justify; margin-top: 0pt; margin-bottom: 0pt;"><b>&#160;</b></p>
            </td>
            <td style="width: 90%; vertical-align: top;">
                <p style="text-align: justify; margin-top: 0pt; margin-bottom: 0pt;">On December 8, 2023, the Company completed its previously announced sale of an aggregate of 1,265,000 common shares of the Company (each, a "<b>Common Share</b>") at a purchase price of US$1.00 per Common Share in an underwritten public offering (the "<b>Offering</b>") priced at-the-market under the Nasdaq Capital Market (the "<b>Nasdaq</b>") rules. The 1,265,000 Common Shares includes 165,000 Common Shares issued pursuant to the full exercise by an underwriter of its over-allotment option. The aggregate gross proceeds to the Company were approximately US$1.265 million, before the underwriters' discount and commissions for the facilitation of the Offering.</p>
            </td>
        </tr>
        <tr>
            <td style="width: 10%; vertical-align: top;">&#160;</td>
            <td style="width: 90%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
            <td style="width: 10%; vertical-align: top;">
                <p style="text-align: justify; margin-top: 0pt; margin-bottom: 0pt;"><b>Item 5</b></p>
            </td>
            <td style="width: 90%; vertical-align: top;">
                <p style="text-align: justify; margin-top: 0pt; margin-bottom: 0pt;"><b>Full Description of Material Changes:</b></p>
            </td>
        </tr>
        <tr>
            <td style="width: 10%; vertical-align: top;">&#160;</td>
            <td style="width: 90%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
            <td style="width: 10%; vertical-align: top;">
                <p style="text-align: justify; margin-top: 0pt; margin-bottom: 0pt;"><b>&#160;</b></p>
            </td>
            <td style="width: 90%; vertical-align: top;">
                <p style="text-align: justify; margin-top: 0pt;">On December 8, 2023, the Company completed its previously announced Offering of an aggregate of 1,265,000 Common Shares of the Company at a purchase price of US$1.00 per Common Share and priced at-the-market under the Nasdaq rules. The aggregate gross proceeds to the Company were approximately US$1.265 million, before the underwriter's discount and commissions for the facilitation of the Offering.</p>
                <p style="text-align: justify;">The Benchmark Company acted as the sole book-running underwriter and R.F. Lafferty acted as co-underwriter for the Offering.</p>
                <p style="text-align: justify;">The securities were offered and sold pursuant to a shelf Registration Statement on Form F-3 (File No. 333-273197) that was declared effective by the United States Securities and Exchange Commission (the "<b>SEC</b>") on July 14, 2023. A copy of the final prospectus supplement and accompanying prospectus describing the terms of the offering has been filed with the SEC and is available on its website at <font style="color: #0000ff;"><u>www.sec.gov</u></font>.</p>
                <p style="text-align: justify; margin-bottom: 0pt;">No securities were offered or sold to Canadian purchasers.</p>
            </td>
        </tr>
        <tr>
            <td style="width: 10%; vertical-align: top;">&#160;</td>
            <td style="width: 90%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
            <td style="width: 10%; vertical-align: top;">
                <p style="text-align: justify; margin-top: 0pt; margin-bottom: 0pt;"><b>Item 6</b></p>
            </td>
            <td style="width: 90%; vertical-align: top;">
                <p style="text-align: justify; margin-top: 0pt; margin-bottom: 0pt;"><b>Reliance on Section 7.1(2) of National Instrument 51-102</b></p>
            </td>
        </tr>
        <tr>
            <td style="width: 10%; vertical-align: top;">&#160;</td>
            <td style="width: 90%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
            <td style="width: 10%; vertical-align: top;">
                <p style="text-align: justify; margin-top: 0pt; margin-bottom: 0pt;">&#160;</p>
            </td>
            <td style="width: 90%; vertical-align: top;">
                <p style="text-align: justify; margin-top: 0pt; margin-bottom: 0pt;">Not applicable.</p>
            </td>
        </tr>
    </table>
    <br>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_2"></a><br>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 10%; vertical-align: top;">
                <p style="text-align: justify; margin-top: 0pt; margin-bottom: 0pt;"><b>Item 7</b></p>
            </td>
            <td style="width: 90%; vertical-align: top;">
                <p style="text-align: justify; margin-top: 0pt; margin-bottom: 0pt;"><b>Omitted Information</b></p>
            </td>
        </tr>
        <tr>
            <td style="width: 10%; vertical-align: top;">&#160;</td>
            <td style="width: 90%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
            <td style="width: 10%; vertical-align: top;">
                <p style="text-align: justify; margin-top: 0pt; margin-bottom: 0pt;">&#160;</p>
            </td>
            <td style="width: 90%; vertical-align: top;">
                <p style="text-align: justify; margin-top: 0pt; margin-bottom: 0pt;">Not applicable.</p>
            </td>
        </tr>
        <tr>
            <td style="width: 10%; vertical-align: top;">&#160;</td>
            <td style="width: 90%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
            <td style="width: 10%; vertical-align: top;">
                <p style="text-align: justify; margin-top: 0pt; margin-bottom: 0pt;"><b>Item 8</b></p>
            </td>
            <td style="width: 90%; vertical-align: top;">
                <p style="text-align: justify; margin-top: 0pt; margin-bottom: 0pt;"><b>Executive Officer</b></p>
            </td>
        </tr>
        <tr>
            <td style="width: 10%; vertical-align: top;">&#160;</td>
            <td style="width: 90%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
            <td style="width: 10%; vertical-align: top;">
                <p style="text-align: justify; margin-top: 0pt; margin-bottom: 0pt;">&#160;</p>
            </td>
            <td style="width: 90%; vertical-align: top;">
                <p style="margin-bottom: 0pt; text-align: justify; margin-top: 0pt;">Jennifer Bath</p>
                <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: justify;">Chief Executive Officer</p>
                <p style="margin-top: 0pt; text-align: justify; margin-bottom: 0pt;">(250) 483-0308</p>
            </td>
        </tr>
        <tr>
            <td style="width: 10%; vertical-align: top;">&#160;</td>
            <td style="width: 90%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
            <td style="width: 10%; vertical-align: top;">
                <p style="text-align: justify; margin-top: 0pt; margin-bottom: 0pt;"><b>Item 9</b></p>
            </td>
            <td style="width: 90%; vertical-align: top;">
                <p style="text-align: justify; margin-top: 0pt; margin-bottom: 0pt;"><b>Date of Report</b></p>
            </td>
        </tr>
        <tr>
            <td style="width: 10%; vertical-align: top;">&#160;</td>
            <td style="width: 90%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
            <td style="width: 10%; vertical-align: top;">
                <p style="text-align: justify; margin-top: 0pt; margin-bottom: 0pt;">&#160;</p>
            </td>
            <td style="width: 90%; vertical-align: top;">
                <p style="text-align: justify; margin-top: 0pt; margin-bottom: 0pt;">December 13, 2023</p>
            </td>
        </tr>
    </table>
    <br>
    <hr width="100%" size="5" color="black" noshade="noshade">
</body>

</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
